Does an altered leptin axis play a role in obesity among children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency
The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Congenital adrenal hyperplasia (CAH) patients are at a higher risk to develop obesity. The role of leptin in CAH is still controversial. Our study aimed to evaluate serum levels of leptin, the soluble leptin receptor (sOB-R), and the sOB-R: leptin molar ratios in a cohort of CAH children and adolescents, and their associations with clinical and metabolic parameters. METHODS: We studied 51 CAH patients, aged 5.6-19.6 years (median 11.8, n=30 females) cross-sectionally. All patients had genetically proven CAH and received standard steroid substitution therapy. Blood specimens were taken after overnight fasting between 0800 and 1000 h. For the analyses of leptin and sOB-R, matched pairs were built with healthy Caucasian patients for sex, Tanner stage (TS), chronologic age (CA), and body mass index (BMI). RESULTS: BMI and SDS were significantly elevated compared with the reference population. Leptin levels were not different between matched pairs, whereas sOB-R levels were significantly lower in CAH. Consequently, the sOB-R: leptin molar ratios were significantly decreased in CAH. Correlation analyses in CAH patients revealed significant relationship between leptin and CA, TS, BMI, and homeostasis model assessment of insulin resistance. Similar results were obtained for the matched control group. For sOB-R, we found no significant correlation for CA, TS, or BMI in CAH, but we did in the controls. There were significant correlations for androgens within the CAH group. Additional analyses revealed no correlation with steroid medication or metabolic control. CONCLUSIONS: Our data show that an altered leptin axis with normal serum leptin concentrations but decreased sOB-R serum levels may contribute to the increased risk of overweight and obesity in CAH.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Children with CAH have a higher BMI than do controls due to increased fat mass (273).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [273]
In the citing paper
“Approximately half of pediatric patients are overweight, and 16% to 25% are obese (273-275).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [273]
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Kromeyer-Hauschild, K., Wabitsch, M., Kunze, D., Geller, F., Geiß, H. C., Hesse, V., von Hippel, A., Jaeger, U., Johnsen, D., Korte, W., et al. (2001) · Monatsschrift Kinderheilkunde · doi:10.1007/s001120170107 · Cited by 2,175
Obesity Evaluation and Treatment: Expert Committee Recommendations
Barlow, S. E., & Dietz, W. H. (1998) · Pediatrics · doi:10.1542/peds.102.3.e29 · Cited by 1,565
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432
Congenital Adrenal Hyperplasia
(1987) · New England Journal of Medicine · doi:10.1056/nejm198711263172211 · Cited by 1,409
Congenital adrenal hyperplasia
Speiser, P. W., & White, P. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021561 · Cited by 1,405
Garcia-Mayor, R. V., Andrade, M. A., Rios, M., Lage, M., Dieguez, C., & Casanueva, F. F. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.9.4235 · Cited by 446
Wabitsch, M., Blum, W. F., Muche, R., Braun, M., Hube, F., Rascher, W., Heinze, E., Teller, W., & Hauner, H. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119595 · Cited by 361
Self-citationSoluble Leptin Receptor Represents the Main Leptin Binding Activity in Human Blood
Lammert, A., Kiess, W., Bottner, A., Glasow, A., & Kratzsch, J. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4885 · Cited by 291
Self-citationModulation of Circulating Leptin Levels by Its Soluble Receptor
Huang, L., Wang, Z., & Li, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009795200 · Cited by 263
Chan, J. L., Blüher, S., Yiannakouris, N., Suchard, M. A., Kratzsch, J., & Mantzoros, C. S. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2105 · Cited by 242
Self-citationLarsson, H. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.12.4428 · Cited by 209
Circulating Soluble Leptin Receptor and Free Leptin Index during Childhood, Puberty, and Adolescence
Kratzsch, J., Lammert, A., Bottner, A., Seidel, B., Mueller, G., Thiery, J., Hebebrand, J., & Kiess, W. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020001 · Cited by 187
Self-citationVölkl, T. M. K., Simm, D., Beier, C., & Dörr, H. G. (2006) · PEDIATRICS · doi:10.1542/peds.2005-1005 · Cited by 184
Self-citationAn update of congenital adrenal hyperplasia
NEW, M. I. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1315.009 · Cited by 178 · cited 1×
“Figure 2 Relations of serum levels of sOB-R with chronologic age (CA, upper panel) and BMI (lower panel) in CAH and matched controls. Shown is a non-linear regression analysis of a one phase exponential decay model (best fit, only significant for the controls, confer Table 3, equations: CA, yZ18.42 expC8.140, BMI: yZ2…”
Leptin and Soluble Leptin Receptor Levels in Obese and Weight-Losing Individuals
van Dielen, F. M. H. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.4.1708 · Cited by 166
Charmandari, E., Weise, M., Bornstein, S. R., Eisenhofer, G., Keil, M. F., Chrousos, G. P., & Merke, D. P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8456 · Cited by 164
Devos, R., Guisez, Y., Van der Heyden, J., White, D. W., Kalai, M., Fountoulakis, M., & Plaetinck, G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.29.18304 · Cited by 163
Modulation of Direct Leptin Signaling by Soluble Leptin Receptor
Yang, G., Ge, H., Boucher, A., Yu, X., & Li, C. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0027 · Cited by 136
Obesity in 21-hydroxylase deficient patients
Cornean, R. E., Hindmarsh, P. C., & Brook, C. G. D. (1998) · Archives of Disease in Childhood · doi:10.1136/adc.78.3.261 · Cited by 135
Zastrow, O., Seidel, B. M., Kiess, W., Thiery, J., Keller, E., Böttner, A., & Kratzsch, J. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802432 · Cited by 134
Self-citationRivkees, S. A., & Crawford, J. D. (2000) · PEDIATRICS · doi:10.1542/peds.106.4.767 · Cited by 130
Expression and Characterization of a Putative High Affinity Human Soluble Leptin Receptor
Liu, C. (1997) · Endocrinology · doi:10.1210/en.138.8.3548 · Cited by 125
Groell, R., Lindbichler, F., Riepl, T., Gherra, L., Roposch, A., & Fotter, R. (1999) · The British Journal of Radiology · doi:10.1259/bjr.72.857.10505010 · Cited by 107
Prednisolone in the treatment of adrenal insufficiency: a re-evaluation of relative potency
Punthakee, Z., Legault, L., & Polychronakos, C. (2003) · The Journal of Pediatrics · doi:10.1067/s0022-3476(03)00294-4 · Cited by 95
Völkl, T. M. K., Simm, D., Dötsch, J., Rascher, W., & Dörr, H. G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1069 · Cited by 91
Self-citationA Rapid, Quantitative Immunofunctional Assay for Measuring Human Leptin
Kratzsch, J., Berthold, A., Lammert, A., Reuter, W., Keller, E., & Kiess, W. (2002) · Hormone Research in Paediatrics · doi:10.1159/000057963 · Cited by 85
Self-citationHigh Leptin Concentrations in Serum of Very Obese Children are Further Stimulated by Dexamethasone
Kiess, W., Englaro, P., Hanitsch, S., Rascher, W., Attanasio, A., & Blum, W. (1996) · Hormone and Metabolic Research · doi:10.1055/s-2007-979883 · Cited by 75
Self-citationFalorni, A., Bini, V., Molinari, D., Papi, F., Celi, F., Stefano, G. D., Berioli, M., Bacosi, M. L., & Contessa, G. (1997) · International Journal of Obesity · doi:10.1038/sj.ijo.0800485 · Cited by 73
Leptin: A potential biomarker for childhood obesity?
Venner, A. A., Lyon, M. E., & Doyle–Baker, P. K. (2006) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2006.07.010 · Cited by 71
Sepilian, V., Crochet, J. R., & Nagamani, M. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.10.038 · Cited by 51
Hormonal regulation of human leptin in vivo: effects of hydrocortisone and insulin
Askari, H., Liu, J., & Dagogo-Jack, S. E. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801379 · Cited by 50
Krsek, M., Silha, J. V., Jezková, J., Hána, V., Marek, J., Weiss, V., Stepán, J. J., & Murphy, L. J. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2003.01987.x · Cited by 46
Decreased soluble leptin receptor levels in women with polycystic ovary syndrome
Hahn, S., Haselhorst, U., Quadbeck, B., Tan, S., Kimmig, R., Mann, K., & Janssen, O. E. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02078 · Cited by 44
Kratzsch, J., Schubring, C., Stitzel, B., Böttner, A., Berthold, A., Thiery, J., & Kiess, W. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1454 · Cited by 40
Self-citationInhibition of Cortisol Biosynthesis Decreases Circulating Leptin Levels in Obese Humans
Dagogo-Jack, S. E., Tykodi, G., & Umamaheswaran, I. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0803 · Cited by 36
Energy adaptation to glucocorticoid-induced hyperleptinemia in human beings
Askari, H., Liu, J., & Dagogo-Jack, S. E. (2005) · Metabolism · doi:10.1016/j.metabol.2005.01.035 · Cited by 23
Problems with salivary 17-hydroxyprogesterone determinations using the Salivette device.
Krüger, C., Breunig, U., Biskupek-Sigwart, J., & Hg, D. (1996) · PubMed · Cited by 23
Vierhapper, H., Nowotny, P., Waldhäusl, W. K., & Frisch, H. (1985) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(85)90439-x · Cited by 17
Homoki, J., Sólyom, J., Wachter, U. A., & Teller, W. M. (1992) · European Journal of Pediatrics · doi:10.1007/bf02073884 · Cited by 17
Wabitsch, M. (2000) · PubMed · Cited by 12
Serum leptin levels in patients with 21-hydroxylase deficiency before and after treatment.
Poyrazoğlu, Ş., Günöz, H., & Darendelıler, F. (2003) · PubMed · Cited by 10
Cited by
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
“Children with CAH have a higher body mass index than do controls due to increased fat mass (170).”
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
PW, S., W, A., RJ, A., LS, B., GS, C., DP, M., HFL, M.-B., WL, M., MH, M., SE, O., et al. (2019) · Yearbook of Paediatric Endocrinology · doi:10.1530/ey.16.8.5 · Cited by 300
Nordenström, A., & Falhammar, H. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-0712 · Cited by 158
Clinical perspectives in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency
Bulsari, K., & Falhammar, H. (2016) · Endocrine · doi:10.1007/s12020-016-1189-x · Cited by 149
Metadata
- Authors
- Völkl, T. M. K., Simm, D., Körner, A., Rascher, W., Kiess, W., Kratzsch, J., & Dörr, H. G.
- Affiliations
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-02
- Volume
- 160
- Issue
- 2
- Pages
- 239-247
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2142409942
- Cited by
- 49
- References
- 43
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2022: 3 · 2021: 2 · 2020: 1 · 2019: 2 · 2018: 5 · 2017: 3 · 2016: 3 · 2015: 3 · 2014: 3 · 2013: 2 · 2012: 6
- FWCI
- 1.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Keywords
- congenital adrenal hyperplasia, 21-hydroxylase deficiency, leptin, soluble leptin receptor, obesity, childhood obesity, adolescents, insulin resistance, body mass index, androgens
- MeSH terms
- Adolescent, Adrenal Hyperplasia, Congenital, Child, Child, Preschool, Cross-Sectional Studies, Female, Humans, Insulin Resistance, Male, Obesity, Pregnanetriol, Prospective Studies, Risk Factors, Steroid 21-Hydroxylase, Testosterone, Models, Statistical, 17-alpha-Hydroxyprogesterone, Leptin, Overweight, Receptors, Leptin, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.